Insights & Updates in Treatment of Iron Deficiency Anemia

Sponsored by the Academy for Continued Healthcare Learning (ACHL).

This activity is supported by an educational grant from American Regent.

Specialty: Gastroenterologists, hematologists, oncologists, and other healthcare professionals treating gastrointestinal and cancer related anemia, physicians

Activity Purpose: Iron deficiency anemia (IDA) is associated with myriad disease-related causes in the United States, making it a widespread problem leading to significant morbidity and occasional mortality. Further, it is often easily treatable via either oral or IV iron therapy. Although IDA is a manageable disease with appropriate treatment, widespread undertreatment/underdiagnosis of this disease is apparent across patient demographics. Clinicians require up-to-date knowledge of anemia assessment, diagnosis and management of IDA to reduce its burden and improve clinical outcomes.

Target Audience: This activity is intended for gastroenterologists, hematologists, oncologists, and other healthcare professionals treating gastrointestinal and cancer-related anemia.

Learning Objectives: Upon completion of this activity, participants will be able to:

  • Define IDA etiology, signs/symptoms, and epidemiology across patient subsets.
  • Outline established and novel treatment options for IDA, including efficacy, routes of administration, and clinical appropriateness for IDA across multiple patient subsets and clinical severity levels.
  • Analyze clinical examples of IDA and develop feasible treatment solutions based on relevant symptom severity, practice setting, and patient subset.

This series consists of three CME activities to launch beginning November 2017. As each activity becomes available, the links below will direct learners to the activity details and content.


#1 Insights Activity Title


#2 Insights Activity Title


#3 Q&A Interview Activity Title